BCRX
BioCryst Pharmaceuticals Inc
Price:  
6.13 
USD
Volume:  
2,149,181.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

BCRX Relative Valuation

-570.7%
Upside

As of 2024-05-27, the Relative Valuation of BioCryst Pharmaceuticals Inc (BCRX) is (28.86) USD. This relative valuation is based on P/E multiples. With the latest stock price at 6.13 USD, the upside of BioCryst Pharmaceuticals Inc based on Relative Valuation is -570.7%.

The range of the Relative Valuation is (28.89) - (28.52) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 28.6x - 37.9x 29.3x
Forward P/E multiples 27.7x - 28.2x 27.8x
Fair Price (28.89) - (28.52) (28.86)
Upside -571.2% - -565.3% -570.7%
6.13 USD
Stock Price
(28.86) USD
Fair Price

BCRX Relative Valuation - Historical P/E Data

Date P/E
2024-05-24 -6.07
2024-05-23 -6.26
2024-05-22 -6.59
2024-05-21 -6.35
2024-05-20 -6.07
2024-05-17 -6.21
2024-05-16 -6.40
2024-05-15 -6.29
2024-05-14 -5.30
2024-05-13 -5.57
2024-05-10 -5.26
2024-05-09 -5.28
2024-05-08 -5.05
2024-05-07 -5.20
2024-05-06 -5.21
2024-05-03 -4.40
2024-05-02 -4.43
2024-05-01 -4.52
2024-04-30 -4.09
2024-04-29 -4.22
2024-04-26 -4.12
2024-04-25 -4.12
2024-04-24 -4.17
2024-04-23 -4.33
2024-04-22 -4.36
2024-04-19 -4.38
2024-04-18 -4.45
2024-04-17 -4.53
2024-04-16 -4.56
2024-04-15 -4.62
2024-04-12 -4.72
2024-04-11 -5.05
2024-04-10 -4.82
2024-04-09 -4.75
2024-04-08 -4.56
2024-04-05 -4.55
2024-04-04 -4.55
2024-04-03 -4.68
2024-04-02 -4.64
2024-04-01 -5.00
2024-03-28 -5.03
2024-03-27 -5.10
2024-03-26 -4.96
2024-03-25 -4.86
2024-03-22 -4.96
2024-03-21 -5.43
2024-03-20 -5.41
2024-03-19 -5.30
2024-03-18 -5.02
2024-03-15 -4.95